Stay up to date with the latest developments in artificial intelligence.
The AI Leaders Council has announced the 2026 Corporate AI Outlook Study, a research initiative examining how executives manage AI adoption and deployment. The study’s findings will be previewed during a webcast on January 20, 2026.
A new report from Workday partner Kognitiv shows 80% of HR leaders in the UK want consultancies to better integrate AI, with many already cutting consultancy spend in favor of AI solutions.
Day 1 of the London Blockchain Conference 2025 in London featured discussions on blockchain transparency in AI, EU digital asset regulation, and the evolution of financial infrastructure.
Cisco's latest AI Readiness Index shows that only 13% of organizations, dubbed 'Pacesetters,' consistently outperform peers in deriving value from AI, with most companies struggling to scale due to infrastructure and data challenges.
A new report by MIT Technology Review Insights and Globant finds that nearly three quarters of global pharmaceutical organizations are piloting or deploying agentic AI, with top use cases in compliance, data integration, and patient support.
Microsoft will invest $10 billion in a new AI data hub in Sines, Portugal, in collaboration with Start Campus, Nscale, and NVIDIA, expanding its European AI infrastructure.
OpenAI has begun rolling out GPT-5.1, introducing two updated models—Instant and Thinking—that improve reasoning, tone, and customization in ChatGPT. The release also adds new style controls and personalization options for users.
Baidu has launched ERNIE-4.5-VL-28B-A3B-Thinking, an open-source multimodal AI model that processes text, images, and video with high efficiency. The system activates only 3 billion of its 28 billion parameters and is available under the Apache 2.0 license.
Diversis Capital has merged Genesis Automation Healthcare, Kermit, and Meperia into a unified entity under the Genesis Automation Healthcare brand, creating an AI-enabled platform for hospital supply chain and inventory management.
The second annual Universal 'AI for Health' Summit, organized by AI CoLab, brought together healthcare leaders, educators, and researchers in Washington to discuss practical AI applications in healthcare, according to a press release. The event featured panels on topics including conversational AI, predictive modeling, and governance frameworks.
SOPHiA GENETICS and Element Biosciences announced a partnership to combine AI analytics with sequencing technology, creating an end-to-end workflow for next-generation sequencing in precision medicine research.
At the Future of Health Summit in Los Angeles, more than 65 global health leaders unveiled a roadmap to transform healthcare systems, focusing on AI integration, primary care, and chronic disease management.
CereCore has joined Oracle's enhanced partner program to strengthen its support for healthcare organizations using Oracle Health platforms. The partnership enables CereCore to expand its capabilities in application management, optimization, and IT infrastructure services.
Supreme Group has appointed Olly Johnston as Executive Vice President of Platform Growth and Transformation to lead strategic initiatives across healthcare and life sciences marketing.
Conexiant has launched MDspire, an AI-powered platform that curates and synthesizes medical information for physicians and researchers, combining retrieval-augmented generation with expert review to ensure accuracy.
PureHealth reported AED 20.1 billion in revenue and AED 1.55 billion in net profit for the first nine months of 2025, reflecting growth across its healthcare and insurance operations.
A new report from Silicon Valley Bank reveals that AI-enabled provider operations have attracted the majority of Healthtech investment in 2025, accounting for 44% of total funding and 73% of mega-deals.
ABK Biomedical has secured $35 million in an oversubscribed Series D funding round led by J.P. Morgan Life Sciences Private Capital, with participation from existing investors. The funds will support clinical operations, commercialization of Eye90 microspheres, and expansion of manufacturing capabilities.
GT Biopharma, IDEAYA Biosciences, Zymeworks, and Regeneron Pharmaceuticals have each reported progress in oncology trials and approvals, highlighting continued momentum in biomarker-driven cancer treatments.
Studiosity has announced the acquisition of Norvalid, a company specializing in student authorship validation, to integrate validation tools into its AI learning platform. The deal aims to provide universities with technology that confirms authentic student work while supporting academic integrity.
Daily report covering major AI developments and industry news, with both top stories and complete market updates
